LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 300 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.62 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $102,000 | +15.9% | 3,600 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $88,000 | -59.8% | 3,600 | -45.5% | 0.01% | -57.1% |
| Q4 2019 | $219,000 | +128.1% | 6,600 | +32.0% | 0.01% | +55.6% |
| Q3 2019 | $96,000 | +4700.0% | 5,000 | +614.3% | 0.01% | – |
| Q1 2019 | $2,000 | -89.5% | 700 | +386.1% | 0.00% | -100.0% |
| Q4 2017 | $19,000 | 0.0% | 144 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $19,000 | -29.6% | 144 | -98.1% | 0.00% | 0.0% |
| Q2 2017 | $27,000 | -94.9% | 7,500 | -57.0% | 0.00% | -95.5% |
| Q1 2017 | $530,000 | -73.0% | 17,424 | -86.8% | 0.02% | -68.6% |
| Q4 2016 | $1,965,000 | +281.6% | 131,695 | +654.4% | 0.07% | +204.3% |
| Q3 2016 | $515,000 | +560.3% | 17,457 | +29.0% | 0.02% | +475.0% |
| Q2 2016 | $78,000 | -73.5% | 13,537 | -73.4% | 0.00% | -78.9% |
| Q1 2016 | $294,000 | +281.8% | 50,931 | +832.3% | 0.02% | +375.0% |
| Q4 2015 | $77,000 | – | 5,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |